Skip to main content
Earnings Labs
Larimar Therapeutics, Inc. logo

Larimar Therapeutics, Inc. (LRMR)

NASDAQ·Healthcare·Biotechnology

$4.10

+3.14%

Mkt Cap $396.83M

Analyst Ratings

Buy

6

Hold

0

Sell

0

Price Target (7 analysts)

$12.00

Range $12.00$12.00

Implied Upside

+192.7%

Consensus $12.00 vs current $4.10